KR101857337B1 - 신규한 뉴클레오시드 포스포라미데이트 화합물 및 이의 용도 - Google Patents

신규한 뉴클레오시드 포스포라미데이트 화합물 및 이의 용도 Download PDF

Info

Publication number
KR101857337B1
KR101857337B1 KR1020157027466A KR20157027466A KR101857337B1 KR 101857337 B1 KR101857337 B1 KR 101857337B1 KR 1020157027466 A KR1020157027466 A KR 1020157027466A KR 20157027466 A KR20157027466 A KR 20157027466A KR 101857337 B1 KR101857337 B1 KR 101857337B1
Authority
KR
South Korea
Prior art keywords
alkyl
phenyl
halogenated
fluoro
alkoxy
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Active
Application number
KR1020157027466A
Other languages
English (en)
Korean (ko)
Other versions
KR20150132230A (ko
Inventor
용 왕
리웬 자오
시안 장
셩 비
이핑 가오
홍얀 첸
데종 왕
왕 난
캉 장
유신 리
디 장
Original Assignee
난징 산홈 팔마세우티칼 컴퍼니 리미티드
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by 난징 산홈 팔마세우티칼 컴퍼니 리미티드 filed Critical 난징 산홈 팔마세우티칼 컴퍼니 리미티드
Publication of KR20150132230A publication Critical patent/KR20150132230A/ko
Application granted granted Critical
Publication of KR101857337B1 publication Critical patent/KR101857337B1/ko
Active legal-status Critical Current
Anticipated expiration legal-status Critical

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/16—Drugs for disorders of the alimentary tract or the digestive system for liver or gallbladder disorders, e.g. hepatoprotective agents, cholagogues, litholytics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A61P31/14—Antivirals for RNA viruses
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/70—Carbohydrates; Sugars; Derivatives thereof
    • A61K31/7042—Compounds having saccharide radicals and heterocyclic rings
    • A61K31/7052—Compounds having saccharide radicals and heterocyclic rings having nitrogen as a ring hetero atom, e.g. nucleosides, nucleotides
    • A61K31/706—Compounds having saccharide radicals and heterocyclic rings having nitrogen as a ring hetero atom, e.g. nucleosides, nucleotides containing six-membered rings with nitrogen as a ring hetero atom
    • A61K31/7064—Compounds having saccharide radicals and heterocyclic rings having nitrogen as a ring hetero atom, e.g. nucleosides, nucleotides containing six-membered rings with nitrogen as a ring hetero atom containing condensed or non-condensed pyrimidines
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07H—SUGARS; DERIVATIVES THEREOF; NUCLEOSIDES; NUCLEOTIDES; NUCLEIC ACIDS
    • C07H19/00—Compounds containing a hetero ring sharing one ring hetero atom with a saccharide radical; Nucleosides; Mononucleotides; Anhydro-derivatives thereof
    • C07H19/02—Compounds containing a hetero ring sharing one ring hetero atom with a saccharide radical; Nucleosides; Mononucleotides; Anhydro-derivatives thereof sharing nitrogen
    • C07H19/04—Heterocyclic radicals containing only nitrogen atoms as ring hetero atom
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07H—SUGARS; DERIVATIVES THEREOF; NUCLEOSIDES; NUCLEOTIDES; NUCLEIC ACIDS
    • C07H19/00—Compounds containing a hetero ring sharing one ring hetero atom with a saccharide radical; Nucleosides; Mononucleotides; Anhydro-derivatives thereof
    • C07H19/02—Compounds containing a hetero ring sharing one ring hetero atom with a saccharide radical; Nucleosides; Mononucleotides; Anhydro-derivatives thereof sharing nitrogen
    • C07H19/04—Heterocyclic radicals containing only nitrogen atoms as ring hetero atom
    • C07H19/06—Pyrimidine radicals
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07H—SUGARS; DERIVATIVES THEREOF; NUCLEOSIDES; NUCLEOTIDES; NUCLEIC ACIDS
    • C07H19/00—Compounds containing a hetero ring sharing one ring hetero atom with a saccharide radical; Nucleosides; Mononucleotides; Anhydro-derivatives thereof
    • C07H19/02—Compounds containing a hetero ring sharing one ring hetero atom with a saccharide radical; Nucleosides; Mononucleotides; Anhydro-derivatives thereof sharing nitrogen
    • C07H19/04—Heterocyclic radicals containing only nitrogen atoms as ring hetero atom
    • C07H19/06—Pyrimidine radicals
    • C07H19/10—Pyrimidine radicals with the saccharide radical esterified by phosphoric or polyphosphoric acids

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Organic Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Molecular Biology (AREA)
  • Engineering & Computer Science (AREA)
  • Biochemistry (AREA)
  • Biotechnology (AREA)
  • Genetics & Genomics (AREA)
  • Animal Behavior & Ethology (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Medicinal Chemistry (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Virology (AREA)
  • Oncology (AREA)
  • Communicable Diseases (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Saccharide Compounds (AREA)
  • Epidemiology (AREA)
KR1020157027466A 2013-03-08 2014-03-06 신규한 뉴클레오시드 포스포라미데이트 화합물 및 이의 용도 Active KR101857337B1 (ko)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
CN201310075423 2013-03-08
CN201310075423.5 2013-03-08
PCT/CN2014/073004 WO2014135107A1 (zh) 2013-03-08 2014-03-06 新的核苷氨基磷酸酯化合物及其应用

Publications (2)

Publication Number Publication Date
KR20150132230A KR20150132230A (ko) 2015-11-25
KR101857337B1 true KR101857337B1 (ko) 2018-05-11

Family

ID=51462121

Family Applications (1)

Application Number Title Priority Date Filing Date
KR1020157027466A Active KR101857337B1 (ko) 2013-03-08 2014-03-06 신규한 뉴클레오시드 포스포라미데이트 화합물 및 이의 용도

Country Status (11)

Country Link
US (1) US9963480B2 (cg-RX-API-DMAC7.html)
EP (1) EP2940031B1 (cg-RX-API-DMAC7.html)
JP (1) JP6219414B2 (cg-RX-API-DMAC7.html)
KR (1) KR101857337B1 (cg-RX-API-DMAC7.html)
CN (4) CN108314697B (cg-RX-API-DMAC7.html)
AU (1) AU2014225052B2 (cg-RX-API-DMAC7.html)
BR (1) BR112015020472B1 (cg-RX-API-DMAC7.html)
CA (1) CA2899763C (cg-RX-API-DMAC7.html)
MX (1) MX374244B (cg-RX-API-DMAC7.html)
RU (1) RU2621709C2 (cg-RX-API-DMAC7.html)
WO (1) WO2014135107A1 (cg-RX-API-DMAC7.html)

Families Citing this family (22)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
KR101857337B1 (ko) 2013-03-08 2018-05-11 난징 산홈 팔마세우티칼 컴퍼니 리미티드 신규한 뉴클레오시드 포스포라미데이트 화합물 및 이의 용도
CN104761604A (zh) * 2014-01-02 2015-07-08 江苏豪森药业股份有限公司 尿嘧啶核苷酸类似物及其制备方法和应用
WO2016015638A1 (zh) * 2014-07-30 2016-02-04 南京圣和药业股份有限公司 丙型肝炎病毒抑制剂及其应用
US10526363B2 (en) 2014-08-15 2020-01-07 Merck Sharp & Dohme Corp. Substituted phosphoramidate compounds and uses thereof
WO2016044243A1 (en) * 2014-09-16 2016-03-24 Achillion Pharmaceuticals, Inc. Pyrimidine nucleoside phosphoramidate
CN105348342B (zh) * 2014-09-30 2018-09-21 南京正大天晴制药有限公司 核苷氨基磷酸酯化合物及药物组合物和用途
CN106132972B (zh) * 2015-02-06 2018-08-31 银杏树药业(苏州)有限公司 用于治疗hcv感染的氨基磷酸酯
CN106866737B (zh) * 2015-12-11 2020-11-20 南京圣和药物研发有限公司 膦酸衍生物及其应用
PT3512863T (pt) * 2016-09-07 2022-03-09 Atea Pharmaceuticals Inc Nucleótidos de purina 2'-substituídos-n6-substituídos para tratamento de vírus de rna
CN108602842B (zh) * 2016-11-02 2020-10-09 四川科伦博泰生物医药股份有限公司 杂环化合物及其制备方法和用途
US20190358214A1 (en) * 2016-11-17 2019-11-28 Abbvie Inc. Compositions and Methods for Treating HCV Infection
CN108218937B (zh) * 2016-12-13 2022-06-07 南京圣和药业股份有限公司 核苷氨基磷酸酯类化合物的光学异构体及其应用
CN108210509A (zh) * 2016-12-13 2018-06-29 南京圣和药业股份有限公司 新的核苷氨基磷酸脂化合物的组合物及其制备方法
CN108218939B (zh) * 2016-12-13 2022-05-17 南京汇诚制药有限公司 联苯核苷氨基磷酸酯化合物的新晶型及制备方法
CN108218936B (zh) * 2016-12-13 2022-06-07 南京圣和药业股份有限公司 联苯核苷氨基磷酸酯化合物的异构体及其无定型物
CN108218940A (zh) * 2016-12-13 2018-06-29 南京圣和药业股份有限公司 核苷氨基磷酸酯类化合物、其制备方法及用途
CN108218938B (zh) * 2016-12-13 2022-06-07 南京圣和药业股份有限公司 联苯核苷氨基磷酸酯化合物的晶型及其制备方法与用途
CN108201539B (zh) * 2016-12-16 2022-04-19 南京汇诚制药有限公司 联苯核苷氨基磷酸酯化合物的应用
CN109419806B (zh) * 2017-08-23 2023-06-20 南京圣和药业股份有限公司 抗病毒组合物及其应用
CN108997426B (zh) * 2018-07-19 2020-11-13 大连理工大学 靶向Hsp60的黄酮烷氧基氨基磷酸酯衍生物、制备及应用
EP3997098A4 (en) * 2019-07-12 2023-10-11 Canopy Growth Corporation Cannabinoid derivatives
CN115340586A (zh) * 2021-05-12 2022-11-15 上海翰森生物医药科技有限公司 核苷氨基磷酸酯类似物、其制备方法和应用

Citations (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2008121634A2 (en) * 2007-03-30 2008-10-09 Pharmasset, Inc. Nucleoside phosphoramidate prodrugs

Family Cites Families (13)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2002039952A2 (en) * 2000-11-16 2002-05-23 Newbiotics, Inc. Synergistic ecta compositions
SG182849A1 (en) * 2003-04-25 2012-08-30 Gilead Sciences Inc Antiviral phosphonate analogs
AU2005317081A1 (en) 2004-10-21 2006-06-22 Merck & Co., Inc. Fluorinated pyrrolo[2,3-d]pyrimidine nucleosides for the treatment of RNA-dependent RNA viral infection
GB0503642D0 (en) 2005-02-22 2005-03-30 Younane Paul P M An exercise apparatus
WO2006116557A1 (en) 2005-04-25 2006-11-02 Genelabs Technologies, Inc. Nucleoside compounds for treating viral infections
PA8852101A1 (es) 2008-12-08 2010-07-27 Medivir Ab Nucleótidos uracil ciclopropílicos
AR074897A1 (es) 2008-12-23 2011-02-23 Pharmasset Inc Fosforamidatos de nucleosidos
JO3027B1 (ar) 2009-05-14 2016-09-05 Janssen Products Lp نيوكليوسيدات يوراسيل سبيرواوكسيتان
WO2012040127A1 (en) * 2010-09-22 2012-03-29 Alios Biopharma, Inc. Substituted nucleotide analogs
AU2012308900A1 (en) * 2011-09-12 2013-05-09 Idenix Pharmaceuticals, Inc. Compounds and pharmaceutical compositions for the treatment of viral infections
EA024297B1 (ru) * 2011-12-20 2016-09-30 Рибосайенс Ллк 2',4'-дифтор-2'-метилзамещенные нуклеозидные производные в качестве ингибиторов репликации рнк вируса гепатита с
KR101857337B1 (ko) 2013-03-08 2018-05-11 난징 산홈 팔마세우티칼 컴퍼니 리미티드 신규한 뉴클레오시드 포스포라미데이트 화합물 및 이의 용도
CN104761604A (zh) 2014-01-02 2015-07-08 江苏豪森药业股份有限公司 尿嘧啶核苷酸类似物及其制备方法和应用

Patent Citations (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2008121634A2 (en) * 2007-03-30 2008-10-09 Pharmasset, Inc. Nucleoside phosphoramidate prodrugs

Non-Patent Citations (1)

* Cited by examiner, † Cited by third party
Title
Journal of Organic Chemistry, Vol. 76, Pages 8311-8319(공개일: 2011. 9. 14.)*

Also Published As

Publication number Publication date
RU2621709C2 (ru) 2017-06-07
WO2014135107A1 (zh) 2014-09-12
EP2940031B1 (en) 2017-09-27
RU2015142682A (ru) 2017-04-13
EP2940031A1 (en) 2015-11-04
US20150361123A1 (en) 2015-12-17
MX374244B (es) 2025-03-05
BR112015020472A2 (pt) 2020-01-28
US9963480B2 (en) 2018-05-08
CN104031104A (zh) 2014-09-10
JP2016510043A (ja) 2016-04-04
EP2940031A4 (en) 2016-01-27
CN108314697B (zh) 2021-05-07
KR20150132230A (ko) 2015-11-25
CN108314697A (zh) 2018-07-24
CA2899763C (en) 2020-03-10
CN109503686B (zh) 2022-03-11
CN109503686A (zh) 2019-03-22
CN104031104B (zh) 2018-04-10
BR112015020472B1 (pt) 2021-01-19
CN108546277A (zh) 2018-09-18
AU2014225052A1 (en) 2015-08-20
JP6219414B2 (ja) 2017-10-25
HK1210619A1 (en) 2016-04-29
CN108546277B (zh) 2021-05-07
AU2014225052B2 (en) 2016-11-10
CA2899763A1 (en) 2014-09-12
MX2015011473A (es) 2016-05-31

Similar Documents

Publication Publication Date Title
KR20150132230A (ko) 신규한 뉴클레오시드 포스포라미데이트 화합물 및 이의 용도
TWI519515B (zh) B型肝炎抗病毒劑
CN110088103B (zh) 用于治疗和预防乙型肝炎病毒感染的新的四氢吡啶并嘧啶化合物
ES2355068T3 (es) Derivado del ácido triarilcarboxílico.
CN104231023B (zh) 三环稠杂环类核苷氨基磷酸酯化合物、其制备方法及应用
KR102933784B1 (ko) 피롤 화합물
CN105315319B (zh) 丙型肝炎病毒抑制剂及其应用
JP2017502975A (ja) ウラシルヌクレオチド類縁体、それらの製造方法、およびそれらの用途
KR20210126636A (ko) 이환식 설폰아마이드
TWI639613B (zh) Hcv聚合酶抑制劑
HK1210619B (en) Nucleoside phosphoramidate compounds for use in the treatment of hcv
WO2023205645A1 (en) Bicyclic compounds
HK40011886A (en) Novel tetrahydropyridopyrimidines for the treatment and prophylaxis of hepatitis b virus infection
WO2018110643A1 (ja) 抗ウイルス活性を示すヌクレオシド誘導体
TW201815396A (zh) Hcv聚合酶抑制劑

Legal Events

Date Code Title Description
A201 Request for examination
PA0105 International application

Patent event date: 20151005

Patent event code: PA01051R01D

Comment text: International Patent Application

PA0201 Request for examination
PG1501 Laying open of application
E902 Notification of reason for refusal
PE0902 Notice of grounds for rejection

Comment text: Notification of reason for refusal

Patent event date: 20170419

Patent event code: PE09021S01D

E90F Notification of reason for final refusal
PE0902 Notice of grounds for rejection

Comment text: Final Notice of Reason for Refusal

Patent event date: 20171027

Patent event code: PE09021S02D

E701 Decision to grant or registration of patent right
PE0701 Decision of registration

Patent event code: PE07011S01D

Comment text: Decision to Grant Registration

Patent event date: 20180419

GRNT Written decision to grant
PR0701 Registration of establishment

Comment text: Registration of Establishment

Patent event date: 20180504

Patent event code: PR07011E01D

PR1002 Payment of registration fee

Payment date: 20180504

End annual number: 3

Start annual number: 1

PG1601 Publication of registration
PR1001 Payment of annual fee

Payment date: 20220427

Start annual number: 5

End annual number: 5

PR1001 Payment of annual fee

Payment date: 20240429

Start annual number: 7

End annual number: 7

PR1001 Payment of annual fee

Payment date: 20250430

Start annual number: 8

End annual number: 8